Completed NA INTERVENTIONAL NCT00004826

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

Sponsor: Memorial Hospital of Rhode Island

Interventions clozapine

Updated 5 times since 2017 Last updated: Mar 24, 2015 Started: Oct 31, 1993 Completion: Nov 30, 1997

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004826, this NA trial focuses on Parkinson Disease and remains completed. Sponsored by Memorial Hospital of Rhode Island, it has been updated 5 times since 1993, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Memorial Hospital of Rhode Island

Data source: FDA Office of Orphan Products Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.